Venous Thromboembolism
From the Journals
COPD linked to higher in-hospital death rates in patients with PAD
COPD was an independent predictor of in-hospital death and of pulmonary embolism in PAD patients.
From the Journals
Treprostinil improves function for complex PAH patients
Adults with CTEPH who received a high dose of subcutaneous treprostinil improved significantly, compared with baseline.
From the Journals
Most oral HRT linked to increased VTE risk
Conference Coverage
Large cohort study IDs prognostic factors in thromboangiitis obliterans
CHICAGO – Ethnicity and limb infection are independent predictors of poor outcomes, including limb amputation, in TAO.
Guidelines
ASH releases new VTE guidelines
A panel of the American Society of Hematology released more than 150 recommendations for dealing with venous thromboembolism.
Conference Coverage
Tofacitinib and TNF inhibitors show similar VTE rates
A review of more than 50,000 U.S. rheumatoid arthritis patients shows similar venous thromboembolism rates with tofacitinib and TNF inhibition.
From the Journals
All patients with VTE have a high risk of recurrence
Researchers suggest rethinking categorization of patients with incident venous thromboembolism.
Conference Coverage
EHR-guided strategy reduces postop VTE events
BOSTON – Missed doses of enoxaparin correlate with increased incidence of deep vein thrombosis.
News
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PAD
Rivaroxaban (Xarelto) is the first direct oral anticoagulant to gain an indication for prevention of cardiovascular events.
Conference Coverage
Obesity paradox extends to PE patients
SAN ANTONIO – The obese patients in the analysis had a lower mortality risk, despite receiving more thrombolytics.
From the Journals
No significant VTE risk for women taking noncyclic COCs